Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > J Korean Cancer Assoc > Volume 23(1); 1991 > Article
Original Article
Phase II trial of 5-FU, etoposide, cisplatin (FEP) combination chemotherapy in unresectable non-small cell lung cancer
Jin Hyuk Choi, Hyun Cheol Chung, Dong Jip Kim, Je Yol Oh, Joon Chang, Eun Hee Koh, Joo Hang Kim, Jae Kyung Rho, Sung Kyu Kim, Won Young Lee, Gwi Eon Kim, John Kyu Loh Juhn
Journal of the Korean Cancer Association 1991;23(1): 120-130.
  • 2,694 Views
  • 17 Download
  • 0 Crossref
  • 0 Scopus
prev next
Full Article

Download PDF Download PDF

Abstract

No abstract available.

  • Cite
    CITE
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Phase II trial of 5-FU, etoposide, cisplatin (FEP) combination chemotherapy in unresectable non-small cell lung cancer
    J Korean Cancer Assoc. 1991;23(1):120-130.
    Close
Cancer Res Treat : Journal of the Korean Cancer Association
© Korean Cancer Association.
Close layer
TOP